TOPPER

Tag Archives | Pharma

News image: Rally for Vaccine Truth

NEWS: Rally Demanding Vaccine Truth at Frank Ogawa Plaza in Solidarity with Rally at the CDC in Atlanta

OAKLAND, Calif., Oct. 19, 2015 (SEND2PRESS NEWSWIRE) — Council for Vaccine Safety, and A Voice for Choice, in collaboration with community leaders, announce that on October 24, 2015 at 12 noon, protesters will rally at Frank Ogawa Plaza in Oakland, Calif. in solidarity with the Truth, Transparency and Freedom Rally happening on the same day […]

Continue Reading
News image: Age Healthier Live Happier book

NEWS: Release and Book Signing of BioTE Medical President Gary Donovitz M.D. ‘Age Healthier Live Happier’ at Age Management Medicine Group (AMMG) Conference

ORLANDO, Fla., April 23, 2015 (SEND2PRESS NEWSWIRE) — BioTE Medical President and Founder Gary Donovitz M.D. releases his book ‘Age Healthier Live Happier – Avoiding Over-Medication through Natural Hormone Balance’ (ISBN: 9780990706458) to kick off the Age Management Medicine Group Conference at JW Marriott / Ritz Carlton Grande Lakes April 23 – 26, 2015.

Continue Reading
News image: Comfortear Lacrisolve

NEWS: Paragon BioTeck Receives CE Mark Approval on Comfortear Lacrisolve Absorbable Punctum Plug

PORTLAND, Ore., Nov. 17, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug. CE mark approval is recognized and associated […]

Continue Reading
News image: ophthalmic pharmaceuticals

NEWS: Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago

PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 – 21.

Continue Reading

NEWS: Novel Protein May Hold Promise for Enhancing Artificial Tear Formulations

PLYMOUTH, Minn., Oct. 14, 2014 (SEND2PRESS NEWSWIRE) — SilkTears, LLC, a privately held, research-based and product-driven biotechnology company, announced today that advances in protein-based excipient technology may allow for the development of artificial tear products that will more closely represent certain characteristics of the natural makeup of the tear film, and may help the significant […]

Continue Reading
News image: Ophthalmic Solution

NEWS: Paragon BioTeck announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available

PORTLAND, Ore., June 4, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler.

Continue Reading
News image: Ophthalmic

NEWS: Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent Readily Available

PORTLAND, Ore., April 9, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.

Continue Reading
News image: Larry Weisenthal MD PhD

NEWS: Test Shown to Reduce Early Cancer Deaths is Now Available to Patients

HUNTINGTON BEACH, Calif., Nov. 14, 2013 (SEND2PRESS NEWSWIRE) — SignatureCLL today announced that the first laboratory test ever shown in a clinical trial to improve one year survival rates in cancer is now available to patients with chronic lymphocytic leukemia (also called CLL). The U.S. cancer physician who invented the test and the British scientist […]

Continue Reading
News image: Ilast ocular care

NEWS: Paragon Puts Ilast Center Stage

PORTLAND, Ore., Nov. 8, 2013 (SEND2PRESS NEWSWIRE) — Leading biopharmaceutical company Paragon BioTeck, Inc. announced today that it plans to launch its new line of products, known as Ilast(R), at the Annual American Academy of Ophthalmology meeting in New Orleans. Paragon signed an exclusive distribution agreement with Horus Pharma to supply Ilast(R) ocular care products […]

Continue Reading
News image: Deer Antler Spray

NEWS: Deer Antler Spray Company Nutronics Labs Encourages Product Comparisons

CHICAGO, Ill., Nov. 6, 2013 (SEND2PRESS NEWSWIRE) — Natural supplement company Nutronics Labs released a statement today encouraging deer antler spray consumers to do thorough product research before buying health supplements online. Nutronics Labs is the leading manufacturer of deer antler spray and boasts the world’s strongest supplements available – but as the popularity of […]

Continue Reading
News image: Phenylephrine

NEWS: Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine

MADISON, N.J. and TIGARD, Ore., April 19, 2013 (SEND2PRESS NEWSWIRE) — Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon’s phenylephrine in the United States on an exclusive basis beginning this month.

Continue Reading
RXCut Plus

RXCut Plus announces website to help people get the best prescription discounts

DOVER, Pa. /CitizenWire/ — RXCut(R) Plus announced this week a new website that is designed to help people get the best prescription price available. ‘Our cutting-edge pharmacy price search is tightly integrated with Google Maps technology making it faster and easier for people to access pharmacy information,’ Gerard Ferro, founder and CEO RXCut(R) Plus, says.

Continue Reading
Laboratory Supply Distributors Corp.

Laboratory Supply Distributors’ latest catalog serves chromatography, biotech, and pharma markets

MILLVILLE, N.J. /CitizenWire/ — Laboratory Supply Distributors Corp., a provider of diverse products for the chromatography, biotechnology, pharmaceutical and environmental industries, today announced the launch of its 2013 catalog. It showcases many new products for the life science and biotech markets.

Continue Reading
BRIDGEPORT, Conn. (SEND2PRESS NEWSWIRE) — Head lice love the holidays as much as kids do, says George Coleman, founder of Dermedics Laboratories and master-mind behind the only non-toxic, FDA registered head lice treatment and repellent used by the U.S. Department of Health and Human Services to treat and prevent head lice infestations. Holiday parties give [...]

Make 2013 a Year Without Head Lice!

BRIDGEPORT, Conn. (SEND2PRESS NEWSWIRE) — Head lice love the holidays as much as kids do, says George Coleman, founder of Dermedics Laboratories and master-mind behind the only non-toxic, FDA registered head lice treatment and repellent used by the U.S. Department of Health and Human Services to treat and prevent head lice infestations. Holiday parties give […]

Continue Reading
CMI

Pharmaceutical Marketing Research Group 2012 Conference to feature CMI’s Mike Mabey

ATLANTA, Ga. /CitizenWire/ — CMI’s Mike Mabey, vice president, client solutions, and Jarod Ricci, senior manager, market analytics, Pfizer (NYSE:PFE), will present ‘Using Information-Seeking Behavior to Drive Segment-Specific Communication Strategies’ at the 2012 PMRG (Pharmaceutical Marketing Research Group) Annual National Conference.

Continue Reading
Highland Ophthalmology Associates

ProKera(R) for Corneal Patients offered by Highland Ophthalmology Associates in New York

NEW WINDSOR, N.Y. /CitizenWire/ — Mary Davidian, M.D., of Highland Ophthalmology Associates, a leading eye surgeon in The Hudson Valley, announces offering her patients a unique corneal wound repair and healing device called ProKera(R). Today, ProKera(R) is the only medical device that can provide wound healing to patients afflicted with a damaged cornea, the outer […]

Continue Reading
Bio-Medical Services

Bio-Medical Services announces needle free allergy treatment, ACTT ‘Allergy Drops’

AUSTIN, Texas /CitizenWire/ — Bio-Medical Services has received USDA approval and is now offering ACTT(TM) – allergy drop immunotherapy – as an alternative method for administering allergy treatment for pet allergy patients. An in-house pilot study is now underway, and preliminary findings are expected in the Fall of 2012.

Continue Reading
Reaction Biology Corporation

Paper published: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity

MALVERN, Pa. /CitizenWire/ — Reaction Biology Corporation (‘RBC’) today announced the publication in Nature Biotechnology, of the largest kinase profiling data set in the public domain, disclosing previously unknown kinase inhibition relationships. The data set was compiled from over 100,000 independent activity assays performed with RBC’s proprietary HotSpot(SM) technology.

Continue Reading
Soy Labs, LLC

Made in Missouri: Soy Labs LLC and Missouri Plant Science Center in Governor’s Spotlight

MEXICO, Mo. /CitizenWire/ — Missouri Gov. Jay Nixon, whose job-creation strategy has focused on investing in science, technology and innovation, and encouraging and incentivizing entrepreneurship, selected Soy Labs and the Missouri Plant Science Center on Friday, as the site to discuss the importance of the Missouri House passing the Missouri Science and Innovation Reinvestment Act.

Continue Reading
Millennium Administrators, Inc.

Millennium Administrators, Inc. to Provide Benefit Admin for Active Fire and Police, in Scranton, Pa.

SCHWENKSVILLE, Pa. (CitizenWire) — Millennium Administrators, Inc., a benefits administrator, has signed a contract with the City of Scranton to provide benefit administration services for over 500 city employees. Millennium is providing administrative oversight for the city benefit program, including cost containment initiatives, claim audits and administrative services

Continue Reading
Business and Decision

ERP Solutions for Pharma Industry offered through partnership of Business & Decision and New Strategies

PHOENIX, Ariz. (CitizenWire) — As a part of Business & Decision’s ongoing focus in the Life Science market, we are delighted to announce a partnership with New Strategies, the creators of ‘AX for Pharma’ an industry leading Enterprise Resource Planning solution for the Pharmaceutical industry. This solution, which is based on Microsoft Dynamics AX, has […]

Continue Reading
Belvidere Pharmacy

Practitioners from Belvidere Pharmacy and Balancing Health ask if there is connection between hormone therapy and breast cancer

SOMERSET, N.J. (CitizenWire) — From the blogosphere to mainstream media, there’s been a recent-and disturbing-buzz on a connection between hormone replacement therapy and a higher risk for advanced-stage breast cancer in post-menopausal women. The recent media focus stems from a study published in the Oct. 2010 issue of the Journal of the American Medical Association. […]

Continue Reading
Laura Winn Johnson

PMRG Meeting: Navigating Healthcare’s Shifting Currents: Essential Techniques for the Healthcare Marketing Researcher

ATLANTA, Ga. (CitizenWire) — CMI, a full-service marketing research company, has been chosen for the second consecutive year to present a session at The Fourth Annual Meeting of the PMRG Institute in Boston, Mass., on Oct. 24-26, 2010. The theme for this year’s conference is ‘Navigating Healthcare’s Shifting Currents: Essential Techniques for the Healthcare Marketing […]

Continue Reading
drug discovery

National Cancer Institute Grant for Epigenetic Platform Awarded to Reaction Biology Corp.

MALVERN, Pa. — Reaction Biology Corporation (RBC) announced today that it has been awarded a Phase II SBIR grant from the National Cancer Institute to expand the reach of its Methyltransferase HotSpot drug discovery platform. The $1.2 million, two-year grant will help fund an expansion of RBC’s methyltransferase screens from 14 to 35 or more.

Continue Reading

Part of the Neotrope® News Network, USA.